M&A Deal Summary

Bruker Acquires BIOCRATES

On June 3, 2025, Bruker acquired life science company BIOCRATES

Acquisition Highlights
  • This is Bruker’s 5th transaction in the Life Science sector.
  • This is Bruker’s 2nd transaction in Austria.

M&A Deal Summary

Date 2025-06-03
Target BIOCRATES
Sector Life Science
Buyer(s) Bruker
Deal Type Add-on Acquisition

Target

BIOCRATES

Innsbruck, Austria
BIOCRATES is a provider of endogenous and exogenous small molecules such as lipids or amino acids, called metabolites. BIOCRATES was founded in 2002 and is based in Innsbruck, Austria.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bruker

Billerica, Massachusetts, United States

Category Company
Founded 1991
Sector Test/Measurement Equipment
Employees11,396
Revenue 3.4B USD (2024)
DESCRIPTION

Bruker is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. Bruker was founded in 1991 and is based in Billerica, Massachusetts.


DEAL STATS #
Overall 48 of 48
Sector: Life Science M&A 5 of 5
Type: Add-on Acquisition M&A Deals 43 of 43
Country: Austria M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-17 NanoString Technologies

Seattle, Washington, United States

NanoString Technologies develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. NanoString Technologies was founded in 2003 and is based in Seattle, Washington.

Buy $393M